Home/Lupin/Rajender K. Saxena
RK

Rajender K. Saxena

President, Global Generics

Lupin

Lupin Pipeline

DrugIndicationPhase
Sugammadex InjectionNeuromuscular blockade reversalApproved (Tentative)
Pitolisant TabletsNarcolepsyApproved (Tentative)
Semaglutide InjectionType 2 Diabetes, ObesityMarket
Novel GLP-1 Receptor AgonistMetabolic DisordersPre-clinical/Clinical
Biosimilars PortfolioOncology, ImmunologyVarious
Plasil®GastroenterologyMarket